From 2025 to 2035 the pet diabetes care devices market will demonstrate steady expansion because of the growing number of diabetic animals in companion care services alongside rising awareness about pet healthcare and increasing veterinary diagnostic technology demand.
Planned monitoring requirements combined with insulin requirements for diabetic pets among dogs and cats create a market need for specialized care devices. Pixel GPS medicine forecasts the market to achieve USD 2,594 million in 2025 but predicts an increase to USD 4,645.5 million by 2035 at a compound annual growth rate (CAGR) of 6%.
Market growth receives fuel from better glucose measurement systems combined with growing activities in self-diagnostic kit adoption as well as the trend of pet owners investing in proactive care for their pets.
Device expenses together with low veterinary knowledge in developing areas and regular monitoring compliance difficulties present barriers against market adoption. The market demands lead manufacturers to develop basic affordable devices for pet owners which includes continuous glucose monitors together with smartphone tracking capabilities.
Key Market Metrics
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 2,594 million |
| Industry Value (2035F) | USD 4,645.5 million |
| CAGR (2025 to 2035) | 6% |
The pet diabetes care devices market contains device and animal type segments due to increasing adoption in veterinary clinics and at-home pet care locations. The market features glucose meters as its prime device type together with insulin delivery devices and continuous glucose monitors (CGMs) and testing strips. Glucose meters stay dominant because they provide simple operation at low cost and broad reach in markets.
The prevalence of diabetes in dogs takes the lead as they constitute most of the device user population owing to their high infection rates and established medical practices. After dogs, cats now show rising demand for veterinary devices focused on feline patients.
Pet owners together with veterinary professionals are now using digital health tools for early diagnosis through regular monitoring because pet diabetes understanding has increased in recent times.
Explore FMI!
Book a free demo
Due to high pet ownership and veterinary healthcare expenditure levels and wide availability of advanced diagnostic tools, North America pet diabetes care devices market continues to dominate the market. Device adoption/clinical innovation is led by United States and Canada.
The Europe region is expanding due to a growing awareness of chronic diseases in pets, rising disposable income, and a growing number of veterinary clinics. Digital and home-use diabetes monitoring devices also see demand driven by Germany, the UK, and France.
Growth in the Asia-Pacific area helps the pet diabetes care devices market the most due to the rising pet population, urbanization, and awareness of pet health. Modern Veterinary Infrastructure Pet Wellness Investments in China, Japan, South Korea, and Australia, countries invest in modern veterinary infrastructure and pet wellness programs to keep up with the changing needs in pet care.
High Cost of Continuous Monitoring and Limited Veterinary Awareness
The global pet diabetes care devices market is categorized into blood glucose monitoring devices and insulin delivery devices. Glucometers, insulin pens, and continuous glucose monitors (CGMs) are adapted from human healthcare, but often cost too much for the average pet owner, especially in multi-pet or economically disadvantaged families.
Furthermore, a lack of awareness among general veterinarians, particularly in rural clinics, regarding the availability and appropriate utilization of advanced diabetes care technology leads to underdiagnoses or suboptimal management. This not only has negative implications for pet outcomes, but also for the widespread adoption of these devices in routine veterinary practice, and consequently limiting market growth.
Humanization of Pets and Advancements in Smart Health Monitoring
The market is set to witness considerable growth propelled by the basic understanding of pets, whereby masters continue treating the animals like family and demand premium healthcare along with disease management.
Growing cognizance about pet obesity, lifestyle diseases, and geriatric diabetes consequently creates a demand for reliable, non-invasive, real-time diabetes care solutions. Wearable glucose sensor technology peaked with the launch of the Pet Monitor, while mobile app connectivity, automated insulin dispensers, and tele-veterinary monitoring are moving diabetes care for pets from a reactive to a proactive approach.
As coverage through pet insurance becomes more prevalent and the availability of veterinary telehealth services grows, an increasing number of owners are embracing smart monitoring tools that can facilitate early diagnosis, better glycaemic control, and improved quality of life for the millions of dogs and cats who are diabetic.
From 2020 to 2024, the market grew due to the growing awareness of pet ownership, easier access to diagnoses, and an increasing occurrence of obesity-related diabetes in cats and dogs.
Most people had their diabetes managed by manually checking their blood sugar levels and taking a few units of insulin here and there; CGMs were still starting to appear only in specialty clinics. But device prices, limited insurance reimbursement and veterinary reticence stunted widespread adoption.
In 2025 to 2035, the market will evolve into fully integrated pet diabetes ecosystems supported by AI-enabled monitoring platforms, user-adjusted insulin regimens, and real-time data exchange between pet owners and veterinarians.
Non-invasive devices, including biosensor collars, skin patches, and saliva-based glucose testing techniques, will become more popular, while connected devices sync to pet health apps that deliver alert reminders, dosage recommendations, and lifestyle tracking.
This is also going to encourage more inclusive and affordable access to advanced care tools like diabetes care to be included in pet wellness plans and insurance coverage.
Market Shifts: A Comparative Analysis (2020 to 2024 vs. 2025 to 2035)
| Market Shift | 2020 to 2024 |
|---|---|
| Regulatory Landscape | Compliance centered on adapting human devices for animal use . |
| Technological Advancements | Introduction of manual glucometers and off-label CGMs . |
| Sustainability Trends | Low emphasis on device reusability or eco-packaging. |
| Market Competition | Led by veterinary suppliers and adapted human device manufacturers . |
| Industry Adoption | Common in specialty veterinary clinics and urban pet hospitals . |
| Consumer Preferences | Focused on basic disease control and occasional vet visits . |
| Market Growth Drivers | Growth driven by pet diabetes prevalence and owner awareness . |
| Market Shift | 2025 to 2035 |
|---|---|
| Regulatory Landscape | Expansion into veterinary-specific device approvals, AI data regulation, and digital health standards . |
| Technological Advancements | Rise of wearable, non-invasive biosensors, cloud platforms, and automated insulin delivery systems . |
| Sustainability Trends | Growing shift to rechargeable monitors, recyclable lancets, and energy-efficient wearable sensors . |
| Market Competition | Entry of pet tech startups, digital health innovators, and veterinary telemedicine providers . |
| Industry Adoption | Broader adoption across home care, mobile vets, rural clinics, and pet wellness programs . |
| Consumer Preferences | Preference for real-time monitoring, automated insights, and personalized care routines . |
| Market Growth Drivers | Expansion fuelled by smart tech, digital pet health platforms, and veterinary practice modernization . |
The United States pet diabetes care devices market, like increasing prevalence of pet obesity and diabetes, robust veterinary care infrastructure, and rising awareness regarding diabetes among pet owners. Devices for monitoring glucose levels, pens for the delivery of insulin, and veterinary glucometers have gained popularity in the clinic as well as at home.
With growing vet recommendations and the rising demand for personalized chronic disease management, pet owners are investing in continuous glucose monitoring (CGM) systems and smart tracking apps. The market is also being bolstered by the presence of some leading pet health companies as well as specialty clinics.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 6.4% |
The UK pet diabetes care devices market is on the rise as pet ownership rates increase, early diagnosis becomes more common, and digital tools are used increasingly in veterinary medicine. Pet parents in the UK are helping their cats and dogs manage chronic conditions like diabetes by going to their vet clinics more and utilizing teemed platforms.
More people across the country are adopting portable glucometers, insulin pen devices and vet-prescribed glucose kits. Moreover, the rise in government initiatives promoting animal health insurance and monitoring of chronic illness is also driving the demand for such at-home monitoring solutions.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 5.8% |
The Europe pet diabetes care devices market is growing at a steady rate, owing to the well-established veterinary infrastructure, growing awareness of pet health, and favourable reimbursement policies in some countries of the region. In countries such as Germany, France and Sweden, vet-prescribed monitoring tools for diabetic pets are on the rise.
Smart diagnostic devices for early detection and regular monitoring of glucose level are being embraced by veterinary clinics, as pet owners prefer non-invasive and easy-to-use glucometers. The growing availability of online pet pharmacies and digital pet health applications is also driving growth.
| Region | CAGR (2025 to 2035) |
|---|---|
| European Union | 6.0% |
Japan pet diabetes care devices market is slowly growing due to the aging pet population in the country, the increasing pet humanization trend, and rising need for accurate diagnostics. Small, quiet and easy-to-use diabetes care devices, such as micro-needles or touch-screen glucometers tailored to small animals, are favoured by Japanese consumers.
The country’s advanced veterinary services, along with a culture that prioritizes long-term pet health and hygiene, encourage routine checks. Diverse aesthetic, portable and minimally invasive care devices are rapidly gaining traction as tech-savvy pet owners look for solutions.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 5.6% |
The South Korea pet diabetes care devices market has been growing at a significant rate and factors such as increasing adoption rates of pets, the rise of premium pet clinics, and the growing prevalence of lifestyle-related pet diseases. Demand for compact and mobile-connected glucose testing kits is significant as urban vet clinics, pet hospitals, and online diagnostic services also integrate diabetic care tools.
Smart wearable pet tech and data-driven health tracking is big business in South Korea, with owners keen to utilise the technology to exert more control over their pet's intimate affairs, from fitting customizable insulin schedules and managing dietary planning. Local brands are also jumping into the space with affordable and accessible vet-grade products.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 6.2% |
As the incidence of diabetes in companion animals increases and pet owners become more familiar with chronic condition management, the pet diabetes care devices market continues to expand rapidly.
With improved advances in veterinary medicine and with an increased focus on early diagnosis and long-term disease management, diabetes care has emerged as a pivotal component of pet health.
In this emerging market, glucose monitoring devices account for the most important tool to help manage blood glucose levels, and veterinary clinics are the clear dominant point of care for diabetic pets. Taken together, these segments capture a transition occurring in the market toward enhanced clinical monitoring and more personalized treatment approaches.
Accurate and minimally invasive glucose monitoring tools are increasingly relied upon by both veterinarians and pet owners to inform insulin dosing, monitor the course of the disease, and minimize hypoglycemic events.
Veterinary clinics are key for creating treatment plans, educating pet parents and ensuring pet parents adhere to scheduled glucose tests. As pet health technology continues to evolve, both of these market categories continue to dictate the future of the pet diabetes care market, highlighting the importance of reliable diagnostics and supervised care by a veterinarian.
| Device Type | Market Share (2025) |
|---|---|
| Glucose Monitoring Devices | 57.9% |
The glucose monitoring devices segment dominates the pet diabetes care devices market, as these devices provide accurate, real-time tools veterinary doctors and pet owners can use to manage blood glucose levels.
These vary from portable glucometers to continuous glucose monitors (CGMs) to overcome such discrepancies give the early detection of imbalances and help regulate insulin dosages.
Modern glucose monitors for pets require a small blood sample - similar to a human finger prick or they may use sensor-based readings, which eliminate the stressor of the needle entirely for the animal and caregiver alike. Pet-specific models calibrated to feline and canine physiology have been developed by manufacturers and provide accurate and reliable results.
Blood glucose monitors make managing disease on a day-to-day basis a reality - a perfect measure of avoiding those ups and downs that cause lethargy and dehydration, or worse, diabetic ketoacidosis. These tools also facilitate remote monitoring, enabling pet owners to share readings with veterinarians via apps and data platforms.
As a result, glucose monitoring devices are at the forefront of innovation in the proliferation of health tracking devices designed to improve both proactive health tracking and chronic disease care. Its potential widening applications in clinical and home settings will be crucial for effective, enduring diabetic management in pets.
| End-User Segment | Market Share (2025) |
|---|---|
| Veterinary Clinics | 46.4% |
The veterinary clinics segment is expected to dominate the end-user segment of the global pet diabetes care devices market as veterinary clinics are the key building blocks in which diagnosis and initial treatment, as well as management, are performed.
Veterinarians confirm diabetes by using diagnostic tools like blood tests and glucose monitors and determining the severity of it. Clinics create treatment plans, give the first doses of insulin and instruct pet owners on how to monitor and regulate their pets’ glucose levels at home.
In the clinical setting, physicians can tailor their selection of suitable devices for the patients guided by far more intimate knowledge of condition and follow-up education on disease symptoms, as well as lifestyle changes.
These centers also perform routine monitoring to evaluate the effectiveness of treatment and adjust therapy according to glucose patterns and clinical symptoms. Today, many facilities offer integrated platforms to share data with remote consultants, bringing convenience to pet owners with chronic conditions.
The trusted relationships that veterinarians have with pet families bolster adherence to daily monitoring and treatment protocols. However, along with the growth in the diagnosis of pet diabetes and technological advancements, veterinary clinics will continue to be key drivers in the adoption of care devices and improved health outcomes for diabetic animals.
The pet diabetes care devices market is a niche yet emerging segment of the veterinarian diagnostic industry, driven by the increasing prevalence of diabetes in pets, especially in cats and dogs. The market caters to veterinarians and pet owners with devices that assist with monitoring blood glucose levels, delivering insulin accurately, and tracking health metrics.
Some key players are devices that do species-specific calibration, portable glucometers, continuous glucose monitoring (CGM), and Bluetooth-enabled apps. This market consists of animal health companies, vet tech providers and pet-oriented medical device manufacturers, addressing diabetes management for both in-clinic and at-home settings.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Zoetis Inc. | 20-24% |
| Trividia Health, Inc. (PetTest) | 15-19% |
| Merck Animal Health | 12-16% |
| UltiMed, Inc. | 8-12% |
| i-SENS, Inc. | 5-9% |
| Other Companies (combined) | 30-40% |
| Company Name | Key Offerings/Activities |
|---|---|
| Zoetis Inc. | Introduced AlphaTRAK 3 glucometer with Bluetooth connectivity and mobile app integration in 2024 , enabling real-time blood glucose tracking for pets . |
| Trividia Health, Inc. | Launched PetTest U-40 insulin syringes and Vet-approved glucometers in 2025 , emphasizing accuracy, affordability, and at-home usability . |
| Merck Animal Health | Released Vetsulin Companion Kits with dosing syringes and treatment tracking guides in 2024 , supporting owner-led diabetes care . |
| UltiMed, Inc. | Expanded its UltiCare VetRx line with reusable insulin pen systems in 2024 , providing dose precision and convenience for pet owners . |
| i-SENS, Inc. | Debuted CareSens Pet blood glucose meters for feline and canine use in 2025 , optimized for low-volume sampling and veterinary calibration . |
Key Company Insights
Zoetis Inc.
Zoetis leads with its AlphaTRAK series, delivering high-accuracy, pet-specific glucose monitoring solutions, integrated with cloud-based data and mobile health tracking tools.
Trividia Health, Inc.
Trividia’s PetTest brand is popular among pet owners and clinics, offering affordable, easy-to-use glucose meters and insulin delivery tools for daily home management.
Merck Animal Health
Merck supports pet diabetes care through its Vetsulin product line, offering full care kits and educational resources to simplify owner-administered treatments.
UltiMed, Inc.
UltiMed provides veterinary-exclusive insulin pens and needles, enabling precise dosing, reduced waste, and improved safety for caregivers.
i-SENS, Inc.
i-SENS delivers compact glucometers for veterinary clinics and at-home testing, supporting species-specific algorithms and minimal blood draw requirements.
Other Key Players (30-40% Combined)
Several other companies contribute to the pet diabetes care devices market, focusing on innovative biosensors, connected monitoring, and global pet wellness initiatives:
The overall market size for the pet diabetes care devices market was USD 2,594 million in 2025.
The pet diabetes care devices market is expected to reach USD 4,645.5 million in 2035.
The increasing prevalence of diabetes in companion animals, rising awareness of pet health monitoring, and growing use of glucose monitoring devices in veterinary clinics fuel the pet diabetes care devices market during the forecast period.
The top 5 countries driving the development of the pet diabetes care devices market are the USA, UK, European Union, Japan, and South Korea.
Glucose monitoring devices and veterinary clinics lead market growth to command a significant share over the assessment period.
CGRP Inhibitors Market Trends - Growth, Demand & Forecast 2025 to 2035
Indolent Systemic Mastocytosis treatment Market Insights: Size, Trends & Forecast 2025 to 2035
Intraoperative Fluorescence Imaging Market Report - Demand, Trends & Industry Forecast 2025 to 2035
Lung Cancer PCR Panel Market Trends, Growth, Demand & Forecast 2025 to 2035
Polymyxin Resistance Testing Market Analysis by Product, Testing Methods, End User, and Region - Forecast for 2025 to 2035
Procalcitonin (PCT) Assay Market Analysis by Component, Type, and Region - Forecast for 2025 to 2035
Pet Diabetes Care Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
